Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA386131
Max Phase: Preclinical
Molecular Formula: C58H64N2O15S2
Molecular Weight: 1093.28
Molecule Type: Small molecule
Associated Items:
ID: ALA386131
Max Phase: Preclinical
Molecular Formula: C58H64N2O15S2
Molecular Weight: 1093.28
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](OC(=O)C(C)(C)CCSSc4ccccn4)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
Standard InChI: InChI=1S/C58H64N2O15S2/c1-33-39(72-52(67)46(73-53(68)54(4,5)27-29-76-77-42-26-18-19-28-59-42)44(36-20-12-9-13-21-36)60-50(65)37-22-14-10-15-23-37)31-58(69)49(74-51(66)38-24-16-11-17-25-38)47-56(8,40(63)30-41-57(47,32-70-41)75-35(3)62)48(64)45(71-34(2)61)43(33)55(58,6)7/h9-26,28,39-41,44-47,49,63,69H,27,29-32H2,1-8H3,(H,60,65)/t39-,40-,41+,44-,45+,46+,47-,49-,56+,57-,58+/m0/s1
Standard InChI Key: MBEYWOPHTPPLEH-PIEJWSOOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1093.28 | Molecular Weight (Monoisotopic): 1092.3748 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Vrudhula VM, MacMaster JF, Li Z, Kerr DE, Senter PD.. (2002) Reductively activated disulfide prodrugs of paclitaxel., 12 (24): [PMID:12443783] [10.1016/s0960-894x(02)00784-9] |
2. Ganesh T.. (2007) Improved biochemical strategies for targeted delivery of taxoids., 15 (11): [PMID:17419065] [10.1016/j.bmc.2007.03.041] |
Source(1):